These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21917732)

  • 1. Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.
    Böselt I; Tramma D; Kalamitsou S; Niemeyer T; Nykänen P; Gräf KJ; Krude H; Marenzi KS; Di Candia S; Schöneberg T; Schulz A
    Nephrol Dial Transplant; 2012 Apr; 27(4):1521-8. PubMed ID: 21917732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.
    Chen CH; Chen WY; Liu HL; Liu TT; Tsou AP; Lin CY; Chao T; Qi Y; Hsiao KJ
    J Hum Genet; 2002; 47(2):66-73. PubMed ID: 11916004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.
    Spanakis E; Milord E; Gragnoli C
    J Cell Physiol; 2008 Dec; 217(3):605-17. PubMed ID: 18726898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
    Neocleous V; Skordis N; Shammas C; Efstathiou E; Mastroyiannopoulos NP; Phylactou LA
    Metabolism; 2012 Jul; 61(7):922-30. PubMed ID: 22386940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
    Schöneberg T; Schulz A; Biebermann H; Grüters A; Grimm T; Hübschmann K; Filler G; Gudermann T; Schultz G
    Hum Mutat; 1998; 12(3):196-205. PubMed ID: 9711877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG; Turner M; Morin D
    Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
    Wildin RS; Cogdell DE; Valadez V
    Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.
    Sangkuhl K; Römpler H; Busch W; Karges B; Schöneberg T
    Hum Mutat; 2005 May; 25(5):505. PubMed ID: 15841479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
    Schoneberg T; Yun J; Wenkert D; Wess J
    EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of mutations in the arginine vasopressin receptor 2 gene in congenital nephrogenic diabetes insipidus patients].
    Gu F; Shi Y; Deng J; Jin Z
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1401-5. PubMed ID: 12509923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
    Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
    Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M
    J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.
    Boson WL; Della Manna T; Damiani D; Miranda DM; Gadelha MR; Liberman B; Correa H; Romano-Silva MA; Friedman E; Silva FF; Ribeiro PA; De Marco L
    Genet Test; 2006; 10(3):157-62. PubMed ID: 17020465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.
    Morello JP; Salahpour A; Petäjä-Repo UE; Laperrière A; Lonergan M; Arthus MF; Nabi IR; Bichet DG; Bouvier M
    Biochemistry; 2001 Jun; 40(23):6766-75. PubMed ID: 11389590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
    Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
    Schernthaner-Reiter MH; Adams D; Trivellin G; Ramnitz MS; Raygada M; Golas G; Faucz FR; Nilsson O; Nella AA; Dileepan K; Lodish M; Lee P; Tifft C; Markello T; Gahl W; Stratakis CA
    Eur J Pediatr; 2016 May; 175(5):727-33. PubMed ID: 26795631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.